You are here:
This year, Prof. Dr. Dr. h.c. Matthias H. Tschöp, CEO of Helmholtz Munich, and Prof. Dr. Stefanie Dehnen, a chemist at the Karlsruhe Institute of Technology (KIT), have been awarded the prestigious Hector Science Prize, each receiving €150,000.
Thanks to a new technology called Moscot (“Multi-Omics Single-Cell Optimal Transport”), researchers can now observe millions of cells simultaneously as they develop into a new organ—for example, a pancreas. This groundbreaking method was developed by…
A new report of the Commission on Clinical Obesity, published in The Lancet Diabetes & Endocrinology and endorsed by over 75 medical organizations, has introduced a transformative framework that addresses the limitations of traditional BMI-based…
The clinical onset of type 1 diabetes is preceded by presymptomatic stages, that are marked by the presence of two or more islet autoantibodies. Stage 1 is characterized by normal blood glucose levels, while stage 2 is marked by dysglycemia. However,…
In 2021, a research team led by Prof. Heiko Lickert from Helmholtz Munich discovered the insulin-inhibitory receptor "Inceptor" and its role as a suppressor of the insulin signaling pathway. Now, the researchers have unlocked another, even more…
Almost nine million people are living with type 1 diabetes worldwide. Although this disease can be a life-threatening, it often goes unnoticed and is diagnosed too late. Yet type 1 diabetes can be diagnosed early, long before symptoms appear, by a…
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here: